Literature DB >> 28188572

Gastroparesis post-laparoscopic cholecystectomy in diabetic patients.

Abdulrahman Saleh Al-Mulhim1.   

Abstract

Impairment of gastric emptying is well recognized in patients with diabetes mellitus. The aim of this study was to investigate the influencing factors for gastroparesis syndrome development after laparoscopic cholecystectomy in diabetic patients. This is a case-control study. Clinical data were collected retrospectively for 462 diabetic patients who underwent laparoscopic cholecystectomy from 2008 to 2013. We retrospectively analyzed the incidence of gastroparesis syndrome, clinical features, course of disease, and risk factors. The result showed strong positive relation between the diabetes duration, dose of insulin, patient age, other diabetes complications, and the incidence of gastroparesis. Gastroparesis is not uncommon post-laparoscopic cholecystectomy in diabetic patients.

Entities:  

Keywords:  Gastroparesis; Laparoscopic cholecystectomy

Mesh:

Year:  2017        PMID: 28188572     DOI: 10.1007/s13304-017-0417-0

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  26 in total

1.  Gastrointestinal tract symptoms among persons with diabetes mellitus in the community.

Authors:  D Maleki; G R Locke; M Camilleri; A R Zinsmeister; B P Yawn; C Leibson; L J Melton
Journal:  Arch Intern Med       Date:  2000-10-09

2.  American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis.

Authors:  Henry P Parkman; William L Hasler; Robert S Fisher
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 3.  Treatment of gastroparesis: a multidisciplinary clinical review.

Authors:  T L Abell; R K Bernstein; T Cutts; G Farrugia; J Forster; W L Hasler; R W McCallum; K W Olden; H P Parkman; C R Parrish; P J Pasricha; C M Prather; E E Soffer; R Twillman; A I Vinik
Journal:  Neurogastroenterol Motil       Date:  2006-04       Impact factor: 3.598

4.  Gastric emptying time of fluids and solids in healthy subjects determined by 13C breath tests: influence of age, sex and body mass index.

Authors:  Stephan Hellmig; Florian Von Schöning; Christof Gadow; Stavros Katsoulis; Jürgen Hedderich; Ulrich Robert Fölsch; Eckhard Stüber
Journal:  J Gastroenterol Hepatol       Date:  2006-12       Impact factor: 4.029

5.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

6.  Cholecystectomy and clinical presentations of gastroparesis.

Authors:  Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Jorge Calles; Thomas L Abell; Irene Sarosiek; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

7.  Gastric emptying in patients with gallstone disease with or without dyspepsia: effect of cholecystectomy.

Authors:  M Ibrarullah; B R Mittal; D K Agarwal; B K Das; S P Kaushik
Journal:  Aust N Z J Surg       Date:  1994-04

8.  Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects.

Authors:  P Enck; W Rathmann; M Spiekermann; D Czerner; D Tschöpe; D Ziegler; G Strohmeyer; F A Gries
Journal:  Z Gastroenterol       Date:  1994-11       Impact factor: 2.000

9.  Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus.

Authors:  E Schvarcz; M Palmér; C M Ingberg; J Aman; C Berne
Journal:  Diabet Med       Date:  1996-05       Impact factor: 4.359

10.  Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia.

Authors:  Julia Borg; Olle Melander; Linda Johansson; Kerstin Uvnäs-Moberg; Jens F Rehfeld; Bodil Ohlsson
Journal:  BMC Gastroenterol       Date:  2009-02-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.